Search
for
Sort by
Research 751–780 of 1000+
- Review of Promising Off-Label Use of Deucravacitinib
- Resolution of experimental malaria-associated acute respiratory distress syndrome is Alox12 independent and shows residual inflammation
- Granulomatous Alopecia Areata: A Rare Report With a Review
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Reconsidering the classification of vitiligo and alopecia as cosmetic concerns in Medicaid and Tricare policies
- Alopecia Universalis: Never Give Up?
- Moracin M promotes hair regeneration through activation of the WNT/β-catenin pathway and angiogenesis
- Integrating Psychological Support and Topical Therapy for the Effective Management of Stress-Induced Alopecia Areata: A Case Report
- Immunological Abnormalities In PCOS
- The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis
- 12361 An Unusual Case of Myxedema Coma
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Myeloproliferative disorder associated with alopecia universalis
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- 137 Loss of myeloid Mcpip1 suppresses hair growth and development of epidermal papilloma of the skin
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Alopecia areata in a patient with Coronavirus disease of 2019
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Peculiarities of long-COVID-19 and treatment strategy: a clinical case
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Reply to: “Tofacitinib for the treatment of severe alopecia areata and variants”
- Adipose-derived Stem Cell Secretome and Its Potential Role in the Treatment of Androgenetic Alopecia
- Frontal fibrosing alopecia: An update on the hypothesis of pathogenesis and treatment
- Transcriptional regulation analysis and the potential transcription regulator site in the extended KAP6.1 promoter in sheep
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Regulatory T cells in dominant immunologic tolerance
- Decreased GATA3 levels cause changed mouse cutaneous innate lymphoid cell fate, facilitating hair follicle recycling
- COVID-19: The question of genetic diversity and therapeutic intervention approaches